CDT
CDT Equity Inc.
NASDAQ · USHealthcareBiotechnology
$3.56+13.75%
Price as of Jul 20, 2026
CDT valuation
CDT Equity Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.01x
- Price / sales
- 0.02x
- Price / cash flow
- 0.22x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 1.57x
- EV / EBITDA
- 13.96x
- EV / EBIT
- 24.44x
- Market cap
- $17.3M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.